ストックスクリーナーアプリを入手
7.45
12.54%
0.83
プレマーケット:
7.44
-0.010
-0.13%
前日終値:
$6.62
開ける：
$6.71
24時間の取引高:
1.28M
Relative Volume:
3.69
時価総額：
$226.68M
収益：
$127.70M
当期純損益:
$-121.25M
株価収益率:
-2.3651
EPS:
-3.15
ネットキャッシュフロー:
$-120.32M
1週間 パフォーマンス:
+25.53%
1か月 パフォーマンス:
+8.28%
6か月 パフォーマンス:
-17.13%
1年 パフォーマンス:
-30.95%
1日の値動き範囲:
$6.71
$7.50
1週間の範囲:
$5.88
$7.50
52週間の値動き範囲:
$4.80
$18.75
Iteos Therapeutics Inc Stock (ITOS) Company Profile
ITOS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ITOS
Iteos Therapeutics Inc
|
7.45 | 226.68M | 127.70M | -121.25M | -120.32M | -3.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
490.47 | 128.67B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
585.49 | 60.99B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
599.87 | 36.96B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
236.75 | 29.89B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
252.77 | 25.74B | 3.81B | -644.79M | -669.77M | -6.24 |
Iteos Therapeutics Inc Stock (ITOS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-08-13 | 開始されました | Wells Fargo | Overweight |
| 2021-05-05 | 開始されました | H.C. Wainwright | Buy |
| 2020-10-08 | 開始されました | Robert W. Baird | Outperform |
| 2020-08-18 | 開始されました | JP Morgan | Overweight |
| 2020-08-18 | 開始されました | Piper Sandler | Overweight |
| 2020-08-18 | 開始されました | SVB Leerink | Outperform |
| 2020-08-18 | 開始されました | Wedbush | Outperform |
すべてを表示
Iteos Therapeutics Inc (ITOS) 最新ニュース
ITeos Therapeutics Inc (ITOS) stock on the rise: An overview - uspostnews.com
ITeos Therapeutics Inc [ITOS] Insider Activity: An Update for Investors - knoxdaily.com
Head-To-Head Contrast: iTeos Therapeutics (NASDAQ:ITOS) & Invizyne Technologies (NASDAQ:IZTC) - Defense World
Positive week for iTeos Therapeutics, Inc. (NASDAQ:ITOS) institutional investors who lost 38% over the past year - Yahoo
(ITOS) On The My Stocks Page - news.stocktradersdaily.com
Wellington Management Group LLP Purchases 4,563 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
American Century Companies Inc. Has $522,000 Position in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
KLP Kapitalforvaltning AS Acquires New Position in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
Raymond James Financial Inc. Buys New Holdings in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
Iteos Therapeutics stock hits 52-week low at $5.56 amid market challenges - Investing.com Australia
Iteos Therapeutics stock hits 52-week low at $5.56 amid market challenges By Investing.com - Investing.com South Africa
iTeos Therapeutics, Inc. (NASDAQ:ITOS) Shares Bought by Virtu Financial LLC - Defense World
Charles Schwab Investment Management Inc. Sells 22,939 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
Charles Schwab Investment Management Inc. Decreases Position in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - The AM Reporter
Bank of New York Mellon Corp Sells 35,918 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
Iteos Therapeutics Inc Stock: Cancer Drug Pipeline Shows Promise - Sharewise
iTeos to Present Preclinical Data on Potential Best-In-Class Anti-TREM2 Antibody, EOS-215, and Novel PTPN1/2 Inhibitor at the American Association for Cancer Research Annual Meeting 2025 - GlobeNewswire
Long Term Trading Analysis for (ITOS) - news.stocktradersdaily.com
Victory Capital Management Inc. Has $782,000 Holdings in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
US Bancorp DE Acquires 4,843 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
Wall Street Analysts Think iTeos Therapeutics (ITOS) Could Surge 212.5%: Read This Before Placing a Bet - Yahoo Finance
(ITOS) Investment Report - news.stocktradersdaily.com
Research Analysts Offer Predictions for ITOS Q1 Earnings - Defense World
Analysts Set Expectations for ITOS FY2029 Earnings - Defense World
Wells Fargo & Company Issues Pessimistic Forecast for iTeos Therapeutics (NASDAQ:ITOS) Stock Price - Defense World
HC Wainwright Reaffirms “Buy” Rating for iTeos Therapeutics (NASDAQ:ITOS) - Defense World
JPMorgan Chase & Co. Issues Pessimistic Forecast for iTeos Therapeutics (NASDAQ:ITOS) Stock Price - Defense World
iTeos Therapeutics: Poised for Success with Anti-TIGIT Therapies Amidst Competitive Landscape - TipRanks
iTeos Therapeutics (NASDAQ:ITOS) Earns Outperform Rating from Wedbush - Defense World
iTeos fait le point sur ses activités et publie ses résultats financiers pour le quatrième trimestre et l’exercice 2024 - GlobeNewswire Inc.
H.C. Wainwright maintains Buy on ITOS with $21 price target By Investing.com - Investing.com Canada
iTeos Therapeutics Full Year 2024 Earnings: In Line With Expectations - Simply Wall St
iTeos Therapeutics: Undervalued with Promising Pipeline and Strong Financial Position - TipRanks
Y Intercept Hong Kong Ltd Purchases Shares of 18,468 iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
Iteos Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Iteos Therapeutics Inc expected to post a loss of $1.06 a shareEarnings Preview - TradingView
iTeos Therapeutics, Inc. SEC 10-K Report - TradingView
iTeos Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates - GlobeNewswire
Can iTeos' $655M War Chest Deliver on Its Promising Cancer Immunotherapy Pipeline? - StockTitan
iTeos Therapeutics (ITOS) to Release Earnings on Wednesday - Defense World
ITOS stock touches 52-week low at $7.09 amid market challenges - MSN
(ITOS) Technical Pivots with Risk Controls - Stock Traders Daily
iTeos Therapeutics: Decimated By Collateral Events, Good Chances Of Success Nevertheless - Seeking Alpha
Iteos Therapeutics stock hits 52-week low at $7.05 By Investing.com - Investing.com Canada
Iteos Therapeutics stock hits 52-week low at $7.05 - Investing.com India
Financial Contrast: enGene (NASDAQ:ENGN) versus iTeos Therapeutics (NASDAQ:ITOS) - Defense World
Iteos Therapeutics Inc (ITOS) 財務データ
収益
当期純利益
現金流量
EPS
1.00%
大文字化:
|
ボリューム (24 時間):